Lilly in Houston, Texas

In September, we announced plans for the second of four new manufacturing facilities we’re planning to build in the U.S., in Houston, Texas. We plan to invest more than $6.5 billion in the new site, which will focus on manufacturing small-molecule synthetic medicines across our focus areas of cardiometabolic health, oncology, immunology, and neuroscience.  

Lilly in Houston, Texas, USA
LillyTX_Thumbnail_square
The future of medicine production—and the ability to help people live healthier—requires significant investment.